Washington, DC (May 21, 2026) — The American Pharmacists Association (APhA), joined by state and national pharmacy associations, applauds the U.S. House Ways and Means Committee for advancing H.R. 3164, the Main Street Pharmacy Access Act, common-sense legislation that ensures seniors can receive pharmacist-provided care in their communities. 

Washington, DC (February 9, 2026) — The American Pharmacists Association (APhA) has selected the recipients of the 2026 APhA Immunization Champion Awards, recognizing outstanding individuals, pharmacy professionals, teams, and organizations that have made extraordinary contributions to improving vaccination access, delivery, and public health outcomes in communities across the nation.

Washington, DC (December 18, 2025) – The American Pharmacists Association (APhA) participated in a White House ceremony marking the rescheduling of marijuana as a Schedule III drug. Marijuana’s Schedule I classification imposes strict regulatory requirements that make it difficult for researchers and scientists to obtain it for study. APhA believes that moving marijuana to Schedule III will help accelerate research into its medicinal applications and potentially lead to safer and more effective therapeutic uses.